Application of a Novel Allergen-Specific Immune Signature Directed Approach to Dietary Elimination Therapy in Patients With Eosinophilic Esophagitis (IDiET)
Clinical trial NCT02722148 · COMPLETED
Trial details
- NCT number
- NCT02722148
- Sponsor
- University of North Carolina, Chapel Hill
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-21
- Primary completion
- 2018-04-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.